recombinant Orn degrades small RNAs in vitro, the enzyme has a proclivity for degrading RNA oligomers comprised of two to five nucleotides (nanoRNAs), including 5'-phosphoguanylyl-(3',5')-guanosine. Orn preferentially degrades purine dinucleotides in vitro. Exonuclease assays are carried out using 33P- and Cy5-labled RNA oligomer substrates. Orn is a calcium-insensitive exoribonuclease that selectively degrades purine rich nanoRNAs. (A) Degradation of the 24-mer 5'-33P-CACACACACA-CACACACACACACA-3'. Orn is a poor degrader of cytosine-rich nanoRNA substrates
recombinant Orn degrades small RNAs in vitro, the enzyme has a proclivity for degrading RNA oligomers comprised of two to five nucleotides (nanoRNAs), including 5'-phosphoguanylyl-(3',5')-guanosine. Orn preferentially degrades purine dinucleotides in vitro. Exonuclease assays are carried out using 33P- and Cy5-labled RNA oligomer substrates. Orn is a calcium-insensitive exoribonuclease that selectively degrades purine rich nanoRNAs. (A) Degradation of the 24-mer 5'-33P-CACACACACA-CACACACACACACA-3'. Orn is a poor degrader of cytosine-rich nanoRNA substrates
mutation of gene orn leads to the accumulation of pGpG, which inhibits the function of glutamate-alanine-leucine (EAL) domain-containing enzymes, resulting in increased levels of cyclic-di-GMP and the consequent hyperbiofilm phenotype. EAL domain-containing enzymes hydrolyze cyclic-di-GMP to 5'-phosphoguanylyl-(3',5')-guanosine (pGpG). Mutation of orn drastically increases bacterial susceptibility to quinolones but not to tetracycline, aminoglycoside, or beta-lactam antibiotics. Upregulation of pyocin genes contributes to increased susceptibility to ciprofloxacin in the orn mutant. PrtR stability is reduced by the mutation of orn. Expression levels of prtN and PA0613 in wild-type and DELTAorn mutant strains PA14, phenotypes, overview
the lysates from DELTAorn show 25fold decrease in 5'-phosphoguanylyl-(3',5')-guanosine (pGpG) hydrolysis. Complementation with wild-type, but not active site mutants, restores hydrolysis. Accumulation of pGpG in the DELTAorn strain inhibits PDE-As, increasing cyclic-diguanylate (c-di-GMP) concentration. Increased transcription from the cyclic-diguanylate-regulated pel promoter is observed. Additionally, the cyclic-diguanylate-governed auto-aggregation and biofilm phenotypes are elevated in the DELTAorn strain in a pel-dependent manner. Detection of elevated levels of pGpG and cyclic-diguanylate in the DELTAorn strain. Phenotype, overview
bacterial oligoribonuclease (Orn) is a conserved 3'-to-5' exonuclease. In Pseudomonas aeruginosa, Orn plays a major role in the hydrolysis of pGpG, which is required for cyclic-di-GMP homeostasis. Orn is involved in the degradation of nanoRNAs, which can alter global gene expression by serving as transcription initiation primers. And Orn is required for the type III secretion system and pathogenesis of Pseudomonas aeruginosa, indicating a role of Orn in the bacterial response to environmental stimuli. Orn is required for the tolerance of Pseudomonas aeruginosa to ciprofloxacin, role of Orn in bacterial resistance to antibiotics. And role of Orn in genome integrity and bacterial resistance to quinolones. Oligoribonuclease is required for bacterial resistance to fluoroquinolones
oligoribonuclease (Orn), an exoribonuclease that hydrolyzes two- to five-nucleotide-long RNAs, is the primary enzyme responsible for degrading 5'-phosphoguanylyl-(3',5')-guanosine (pGpG) in cells. Orn binds to pGpG specifically and can cleave it into GMP. pGpG inhibits RocR phosphodiesterase activity by binding to the active site and competing for cyclic diguanylate binding in the active site, and excess pGpG extends cyclic diguanylate half-life in vitro
oligoribonuclease (Orn), which had earlier been established as an essential enzyme in most bacteria involved in the recycling of RNA into ribonucleotides, acts as c-di-GMP PDB-B in Pseudomonas aeruginosa cleaving diguanylate into (pGpG), and pGpG then into GMP
the oligoribonuclease (Orn) is a manganese-dependent 3'->5' exonuclease that produces 5'-phosphorylated ribonucleotide monomers from polyribonucleotides, and it is important in providing homeostatic control of intracellular pGpG under native physiological conditions as well as in cyclic diguanylate (c-di-GMP) signaling in Pseudomonas aeruginosa. It is the primary enzyme responsible for 5'-phosphoguanylyl-(3',5')-guanosine (pGpG) degradation in Pseudomonas aeruginosa cells, it degrades pGpG and prevents its accumulation in the bacterial cells. pGpG reduces the rate of c-di-GMP degradation in cell lysates and inhibits the activity of EAL-dependent phosphodiesterases (PA2133, PvrR, and purified recombinant RocR) from Pseudomonas aeruginosa. pGpG-dependent inhibition is alleviated by the addition of Orn. Orn is essential for the viability of Escherichia coli
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
belongs to space group P21, with unit cell parameters a = 49.9, b = 76.6, c = 61.7, 90.0, 93.55, 90.0, to 19.97-2.09 A resolution, opposing dimeric arrangement, with the catalytic DEDD residues from one monomer closely juxtaposed with a large basic patch on the other monomer
construction of an enzyme knockout mutant by gene replacement, Pseudomonas aeruginosa DELTAorn mutant has high intracellular cyclic diguanylate (c-di-GMP) levels, causing this strain to overexpress extracellular polymers and overproduce biofilm. Mutant DELTAorn cells possess highly elevated 5'-phosphoguanylyl-(3',5')-guanosine (pGpG) levels
construction of an enzyme knockout mutant by gene replacement, Pseudomonas aeruginosa DELTAorn mutant has high intracellular cyclic diguanylate (c-di-GMP) levels, causing this strain to overexpress extracellular polymers and overproduce biofilm. Mutant DELTAorn cells possess highly elevated 5'-phosphoguanylyl-(3',5')-guanosine (pGpG) levels
generation of enzyme mutant DELTAorn, mRNA levels of pyocin biosynthesis genes in the DELTAorn mutant compared to those in wild-type strain PA14. Mutation of orn drastically increases bacterial susceptibility to quinolones but not to tetracycline, aminoglycoside, or beta-lactam antibiotics. Upregulation of pyocin genes contributes to increased susceptibility to ciprofloxacin in the orn mutant. PrtR stability is reduced by the mutation of orn
generation of enzyme mutant DELTAorn, mRNA levels of pyocin biosynthesis genes in the DELTAorn mutant compared to those in wild-type strain PA14. Mutation of orn drastically increases bacterial susceptibility to quinolones but not to tetracycline, aminoglycoside, or beta-lactam antibiotics. Upregulation of pyocin genes contributes to increased susceptibility to ciprofloxacin in the orn mutant. PrtR stability is reduced by the mutation of orn
generation of enzyme mutant DELTAorn. The lysates from DELTAorn show 25fold decrease in 5'-phosphoguanylyl-(3',5')-guanosine (pGpG) hydrolysis. Complementation with wild-type, but not active site mutants, restores hydrolysis. Accumulation of pGpG in the DELTAorn strain inhibits PDE-As, increasing cyclic-diguanylate (c-di-GMP) concentration. Increased transcription from the cyclic-diguanylate-regulated pel promoter is observed. Additionally, the cyclic-diguanylate-governed auto-aggregation and biofilm phenotypes are elevated in the DELTAorn strain in a pel-dependent manner. Detection of elevated levels of pGpG and cyclic-diguanylate in the DELTAorn strain
generation of enzyme mutant DELTAorn. The lysates from DELTAorn show 25fold decrease in 5'-phosphoguanylyl-(3',5')-guanosine (pGpG) hydrolysis. Complementation with wild-type, but not active site mutants, restores hydrolysis. Accumulation of pGpG in the DELTAorn strain inhibits PDE-As, increasing cyclic-diguanylate (c-di-GMP) concentration. Increased transcription from the cyclic-diguanylate-regulated pel promoter is observed. Additionally, the cyclic-diguanylate-governed auto-aggregation and biofilm phenotypes are elevated in the DELTAorn strain in a pel-dependent manner. Detection of elevated levels of pGpG and cyclic-diguanylate in the DELTAorn strain